Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Xiaodong Li, Michael S. Ominsky, Kelly Warmington, +17

Journal of Bone and Mineral Research

SclerostinImmunologyOrthopaedic SurgeryRat ModelOsteoporosis +15

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

Jonathan D. Oliner, Hosung Min, Juan Leal, +40

Cancer Cell

Selective InhibitionAngiogenesisMedicineTumor GrowthVascular Biology +6

APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity

Gang Yu, T. Boone, John Delaney, +14

Nature Immunology

Receptors BcmaAllergyAutoimmune DiseaseAdaptive Immune SystemInnate Immune System +8

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

Koji Tamada, Koji Shimozaki, Andrei I. Chapoval, +9

Nature Medicine

Cell TherapyCancer ImmunosurveillanceT-regulatory CellImmunologyTumor Immunity +10

High ε gate dielectrics Gd2O3 and Y2O3 for silicon

J. Kwo, M. Hong, A. R. Kortan, +7

Applied Physics Letters

SemiconductorsMaterials ScienceElectrical EngineeringY2o3 FilmsEngineering +13

Properties of high κ gate dielectrics Gd2O3 and Y2O3 for Si

J. Kwo, M. Hong, A. R. Kortan, +13

Journal of Applied Physics

EngineeringThin Film Process TechnologySilicon On InsulatorSemiconductor DeviceSemiconductors +14

Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation

Xing-Zhong Xia, James Treanor, Giorgio Senaldi, +18

The Journal of Experimental Medicine

T-regulatory CellImmunologyImmune RegulationCell DeathPathology +18

Three-Dimensional Structure of Interleukin-2

Barbara J. Brandhuber, T. Boone, William C. Kenney, +1

Science

ImmunologyImmune RegulationEffector ProteinStructural ScaffoldImmunologic Mechanism +14

Novel Fold and Putative Receptor Binding Site of Granulocyte-Macrophage Colony-Stimulating Factor

Kay Diederichs, T. Boone, P. Andrew Karplus

Science

Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.

Josette Carnahan, Paul Wang, Richard Kendall, +14

PubMed